Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

• Status: Completed
• Trial end date: 2008-02-14
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and efficacy of epinastine nasal spray compared to placebo for the treatment of subjects with seasonal allergic rhinitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Epinastine

Criteria

Inclusion Criteria:

• A documented history of seasonal allergic rhinitis to mountain cedar or other spring pollen

Exclusion Criteria:

• Significant medical condition

• Significant nasal abnormality

• Significant cardiac condition

• Recent infection

• Use of other allergy medication during the study

• Use of asthma medication other than as-needed albuterol